Hanwha Q Cells became the first company to receive the highest grade under South Korea's carbon certification program for solar modules with seven earning grade 1 certification from the Ministry of Trade, Industry and Energy (MOTIE).
The grade 1 certified modules will be available starting next month, said a Hanwha Q Cells official.
Under the MOTIE’s carbon certification program, the carbon footprint of solar power projects is taken into consideration when prioritizing new installations.
Launched July 22, the program divides solar modules into three categories based on the amount of carbon emitted during its manufacturing and installation.
Grade 1 solar modules, which emit no more than 670 kilograms of carbon per kilowatt of energy generated, are eligible for government subsidies.
The carbon certification program will help reduce carbon emissions from solar modules in South Korea by 10 percent, the equivalent of planting 2 million pine trees or reducing greenhouse gases by 230,000 metric tons annually.


Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10%
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
One Percent Rule Checklist For Safer Forex Trading Risk
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



